IACM-Bulletin of 04 May 2020
- IACM: Ensuring continuity of treatment during the COVID-19 pandemic for patients using Cannabis and cannabinoid medicines.
- A glimpse @ the past
IACM: Ensuring continuity of treatment during the COVID-19 pandemic for patients using Cannabis and cannabinoid medicines.
In 2019 the WHO Expert Committee on Drug Dependence declared that preparations of cannabis have shown therapeutic potential for various medical conditions.
During this pandemic it is imperative we ensure patients who use Cannabis for the management of their medical conditions continue to fully realize their rights, in particular the safe and uninterrupted access to their treatment as required by public health.
The IACM and the Society of Cannabis Clinicians, together with other organisations, have therefore written a communication to the UN Human Rights representatives, expressing concerns, among other things, about the following:
In regard to access we recommend: Medical Cannabis dispensaries be deemed essential services, regulations be implemented to allow and encourage online ordering, curbside and home delivery and provide guidance on standard operating procedures in the face of the pandemic (e. Guidance on handling products, money, credit cards or ID cards, rules for physical distancing, etc.). Traditional medical practitioners and indigenous healers must also be granted recognition as essential services.
In regard to medical practice we recommend: Physician consultation via telemedicine be made available and if possible maintain the same team of caregivers. If not then ensure that the new medical team doesn't discontinue or delay treatment. Expiration dates for existing medical Cannabis documents need to be extended until after the crisis has abated.
The full letter can be found here:
IACM Website
SCC Website
A glimpse @ the past
One year ago
- Science/USA: The legalisation of cannabis reduced the use of cannabis by adolescents
- Israel: Government wants to ease access to medical cannabis
Two years ago
- IACM: The journal “Cannabis and Cannabinoid Research” will be transitioning to a hybrid publication
- UK: Government wants to allow limited access to the medical use of cannabis
- Science/Human: Nabilone improves agitation and other behavioural symptoms in patients with Alzheimer’s disease
- Georgia: The Constitutional Court rules that people can no longer be punished for using cannabis
Online Events 2020
Please find all information of IACM Online Events including free videos of the webinars here.
Conference 2022
The 12th IACM Conference on Cannabinoids in Medicine will be we be held on 20 and 21 October 2022 together with the Swiss SSCM in Basel/Switzerland.
Members only
Regular members can sign up for the new member area of the IACM to access exclusive content.
You need to become a regular member of the IACM to access the new member area.
IACM on Twitter
Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.